In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
January 13th, 2010 | 27 | Yes |
Find On: PubMed — Wikipedia — Google
CAS Number: 885500-12-9
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.83 | 6.63 | -56.58 | 5 | 7 | 1 | 102 | 385.879 | 4 | ↓ |
Hi High (pH 8-9.5) | 1.83 | 6.36 | -11.34 | 4 | 7 | 0 | 100 | 384.871 | 4 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AKT2-2-E | Serine/threonine-protein Kinase AKT2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2 | 0.45 | Binding ≤ 10μM |
CP2C9-1-E | Cytochrome P450 2C9 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1000 | 0.31 | ADME/T ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AKT2_HUMAN | P31751 | Serine/threonine-protein Kinase AKT2, Human | 2.2 | 0.45 | Binding ≤ 1μM |
AKT2_HUMAN | P31751 | Serine/threonine-protein Kinase AKT2, Human | 2.2 | 0.45 | Binding ≤ 10μM |
CP2C9_HUMAN | P11712 | Cytochrome P450 2C9, Human | 1000 | 0.31 | ADME/T ≤ 10μM |
Description | Species |
---|---|
Activation of BAD and translocation to mitochondria | |
Activation of PKB | |
AKT phosphorylates targets in the cytosol | |
AKT phosphorylates targets in the nucleus | |
AKT-mediated inactivation of FOXO1A | |
CD28 dependent PI3K/Akt signaling | |
Constitutive PI3K/AKT Signaling in Cancer | |
CTLA4 inhibitory signaling | |
CYP2E1 reactions | |
deactivation of the beta-catenin transactivating complex | |
Downregulation of ERBB2:ERBB3 signaling | |
G beta:gamma signalling through PI3Kgamma | |
GPVI-mediated activation cascade | |
Inhibition of TSC complex formation by PKB | |
Negative regulation of the PI3K/AKT network | |
PDE3B signalling | |
PIP3 activates AKT signaling | |
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | |
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | |
Translocation of GLUT4 to the plasma membrane | |
VEGFR2 mediated vascular permeability | |
Xenobiotics |
No pre-computed analogs available. Try a structural similarity search.